Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.72    0.48 (1.40%)
Bid:
34.80
Ask:
35.52
Spread: 0.72 (2.069%)
Market Cap: £555.18m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Pre-Close Year End Trading Update

19 Jun 2025 07:00

RNS Number : 4741N
Hays PLC
19 June 2025
 

PRE-CLOSE YEAR END TRADING UPDATE

19 June 2025

 

c.£45m pre-exceptional operating profit expected in FY25 primarily due to more challenging Perm markets

Activity levels during our fourth quarter (ending 30 June) have reduced sequentially driven primarily by broad-based weakness in Perm markets globally reflecting low levels of client and candidate confidence as a result of macroeconomic uncertainty. Temp & Contracting activity continues to be more resilient.

We currently expect Group like-for-like net fees to decline by 9% YoY in Q4 (8% on a working day adjusted basis) against a soft prior-year comparative, with Perm and Temp & Contracting down 14% and 5% respectively.

Our current cost base on a periodic and constant currency basis has improved to c.£75m from c.£76m in Q3. However, given the largely fixed short-term nature of our cost base there has been a high drop-through of lower net fees to profitability and, as a result, we currently expect FY25 pre-exceptional operating profit of c.£45m*

At a regional level, we expect like-for-like net fees in our largest country Germany to decrease by 5% with continued stability in Contracting but weaker conditions in Perm and Temp, primarily due to a subdued Automotive sector. Perm has also weakened in the UK&I and we expect a 13% divisional net fee decline, and similarly in ANZ where net fees are expected to be down 9% YoY.

Net fees are expected to decline by 9% YoY in RoW. EMEA ex-Germany (net fees down 13%) has experienced challenging Perm markets, particularly in France. Asia (net fees down 3%) is stable overall. Americas (net fees down 1%) with 5% YoY growth in North America where markets remain stable.

Cash performance remains in line with normal trends and we expect a modest net cash position at year-end.

We expect current challenging market conditions to persist into FY26 and remain committed to delivering our focused strategy. Our initiatives to improve net fee productivity in real terms and back-office efficiency will be important drivers of medium-term profit recovery when the market recovers.

 

* Company compiled consensus pre-exceptional operating profit for FY25 is £56.4m, based on ten analysts.

 

This announcement contains inside information. The person responsible for releasing this announcement is Rachel Ford, General Counsel & Company Secretary.

 

 

Enquiries

Hays plcJames HiltonKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

Chief Financial OfficerHead of Investor Relations & ESG

 

+44 (0) 203 978 2520+44 (0) 333 010 7092 hays@fgsglobal.com

Conference call

James Hilton and Kean Marden will conduct a conference call for analysts and investors at 9:00am United Kingdom time on 19th June 2025. Participants are invited to register via the URL link below:

https://register-conf.media-server.com/register/BI3505905c97704359b604cfaecfe9ae42

 

Once registered, you will receive a confirmation email, with the details of the call and a personal login link and PIN which will place you directly into the call, without the need to speak to an operator. The call will be recorded and will also be available for playback via the results centre on our investor website.

 

Reporting calendar

Preliminary results for the year ending 30 June 2025

21 August 2025

Trading update for the quarter ending 30 September 2025 (Q1 FY26)

10 October 2025

Trading update for the quarter ending 31 December 2025 (Q2 FY26)

14 January 2026

Cautionary statement

This Trading Update (the "Report") has been prepared in accordance with the Disclosure Guidance and Transparency Rules of the UK Financial Conduct Authority and is not audited. No representation or warranty, express or implied, is or will be made in relation to the accuracy, fairness or completeness of the information or opinions contained in this Report. Statements in this Report reflect the knowledge and information available at the time of its preparation. Certain statements included or incorporated by reference within this Report may constitute "forward-looking statements" in respect of the Group's operations, performance, prospects and/or financial condition. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance shall not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities shall not be taken as a representation that such trends or activities will continue in the future. The information contained in this Report is subject to change without notice and no responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this Report shall be construed as a profit forecast. This Report does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase or subscribe for any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company or any invitation or inducement to engage in investment activity under section 21 of the Financial Services and Markets Act 2000. Past performance cannot be relied upon as a guide to future performance. Liability arising from anything in this Report shall be governed by English Law, and neither the Company nor any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this Report or its contents or otherwise arising in connection with this Report. Nothing in this Report shall exclude any liability under applicable laws that cannot be excluded in accordance with such laws.

 

LEI code: 213800QC8AWD4BO8TH08

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWRRRVAUNAUR
Date   Source Headline
2nd Apr 20207:00 amRNSTrading Update & Equity Placing
1st Apr 202010:00 amRNSTotal Voting Rights
9th Mar 202010:12 amRNSDirector/PDMR Shareholding
4th Mar 20204:40 pmRNSHolding(s) in Company
2nd Mar 202010:00 amRNSTotal Voting Rights
20th Feb 20207:00 amRNSHalf-year Report
12th Feb 202012:09 pmRNSBlock listing Interim Review
3rd Feb 202010:00 amRNSTotal Voting Rights
16th Jan 20207:00 amRNSSecond Quarter Trading Update
6th Jan 20202:43 pmRNSDirector Declaration
2nd Jan 202010:00 amRNSTotal Voting Rights
17th Dec 20194:50 pmRNSHolding(s) in Company
2nd Dec 201910:00 amRNSTotal Voting Rights
13th Nov 20193:49 pmRNSResult of AGM
1st Nov 201910:00 amRNSTotal Voting Rights
29th Oct 20199:40 amRNSDirector/PDMR Shareholding
15th Oct 20197:00 amRNSFirst Quarter Trading Update
1st Oct 20192:22 pmRNSDirector/PDMR Shareholding
1st Oct 201910:12 amRNSDirector/PDMR Shareholding
1st Oct 201910:00 amRNSTotal Voting Rights
30th Sep 20194:27 pmRNSAnnual Financial Report
13th Sep 20193:21 pmRNSDirector/PDMR Shareholding
12th Sep 201912:37 pmRNSDirector/PDMR Shareholding
9th Sep 20193:10 pmRNSDirector/PDMR Shareholding
6th Sep 201910:47 amRNSDirector/PDMR Shareholding
5th Sep 201910:00 amRNSBlock Listing Application
2nd Sep 201910:00 amRNSTotal Voting Rights
30th Aug 201910:27 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSFinal Results
1st Aug 201910:00 amRNSTotal Voting Rights
16th Jul 20197:00 amRNSFinal Quarter Trading Update
11th Jul 201910:16 amRNSDirector/PDMR Shareholding
10th Jul 20199:08 amRNSHolding(s) in Company
1st Jul 201910:00 amRNSTotal Voting Rights
17th Jun 20199:00 amRNSDirectorate Change
3rd Jun 201910:00 amRNSTotal Voting Rights
20th May 20198:30 amRNSDirector Declaration
7th May 201910:00 amRNSChange of Registered Office
1st May 201910:00 amRNSTotal Voting Rights
26th Apr 20193:54 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSThird Quarter Trading Update
1st Apr 201910:00 amRNSTotal Voting Rights
28th Mar 201910:21 amRNSDirector/PDMR Shareholding
13th Mar 20193:08 pmRNSDirector/PDMR Shareholding
12th Mar 201912:05 pmRNSDirector/PDMR Shareholding
1st Mar 201910:00 amRNSTotal Voting Rights
27th Feb 20193:22 pmRNSDirector Declaration
21st Feb 20197:00 amRNSHalf-year Report
20th Feb 20198:30 amRNSDirectorate Change
13th Feb 20193:30 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.